| Literature DB >> 32432555 |
Lena M Stühmann1, Rebecca Paprott2, Christin Heidemann2, Jens Baumert2, Sylvia Hansen3, Daniela Zahn4,5, Christa Scheidt-Nave2, Paul Gellert1.
Abstract
BACKGROUND: Evidence suggests that mobile health app use is beneficial for the prevention and management of type 2 diabetes (T2D) and its associated complications; however, population-based research on specific determinants of health app use in people with and without T2D is scarce.Entities:
Keywords: diabetes mellitus; health promotion; health-related behavior; mobile app; risk factors; smartphone; type 2 diabetes
Year: 2020 PMID: 32432555 PMCID: PMC7270854 DOI: 10.2196/14396
Source DB: PubMed Journal: JMIR Diabetes ISSN: 2371-4379
Figure 1A Flowchart of the hierarchical sample structure for people without known diabetes and people with known type 2 diabetes. Sample sizes (n) are given as unweighted data. Percentages are given as weighted.
Sample characteristics of the initial sample and of the sample of smartphone owners, app users, and nonapp users among individuals without known diabetes. (Data are given as weighted percentage or mean [SD]. Missing data were less than 5% for all variables).
| Variables | Initial sample (n=2327) | Smartphone ownersa (1690/2327; 74.72%b) | App usersa (717/1690; 49.27%) | Nonapp usersa (971/1690; 50.60%) | ||
|
| ||||||
|
| Age (years), mean (SD) | 49.62 (18.55) | 43.69 (15.73) | 40.78 (15.06) | 46.50 (15.88) | |
|
|
| |||||
|
|
| ≥65 | 22.57 | 9.79 | 6.08 | 13.43 |
|
|
| 45-64 | 36.68 | 37.76 | 32.71 | 42.53 |
|
|
| 18-44 | 40.76 | 52.45 | 61.22 | 44.05 |
|
| Gender, female (%) | 51.68 | 50.78 | 50.49 | 50.94 | |
|
|
| |||||
|
|
| Low | 30.70 | 23.61 | 22.58 | 24.68 |
|
|
| Middle | 42.16 | 45.48 | 49.49 | 41.69 |
|
|
| High | 26.93 | 30.63 | 27.51 | 33.49 |
|
| ||||||
|
| BMI (kg/m²), mean (SD) | 25.61 (4.57) | 25.38 (4.50) | 25.59 (4.47) | 25.19 (4.52) | |
|
|
| |||||
|
|
| BMI<25 | 50.55 | 53.31 | 49.71 | 56.70 |
|
|
| 25≤BMI<30 | 31.52 | 29.59 | 32.00 | 27.33 |
|
|
| BMI≥30 | 15.85 | 15.07 | 16.24 | 13.97 |
|
| Hypertension diagnosis (%) | 32.60 | 25.82 | 25.75 | 25.96 | |
|
| Physical activity ≥5 hours/week (%) | 72.49 | 73.46 | 74.28 | 72.59 | |
|
|
|
|
|
|
| |
|
|
| Not smoking | 47.91 | 45.13 | 40.25 | 49.74 |
|
|
| Former smoking | 24.69 | 24.29 | 26.05 | 22.65 |
|
|
| Currently smoking | 27.40 | 30.58 | 33.70 | 27.62 |
|
| Family history of diabetes (%)c | 22.29 | 21.34 | 21.88 | 20.88 | |
|
| ||||||
|
|
| |||||
|
|
| Very good | 24.96 | 28.30 | 33.11 | 23.69 |
|
|
| Good | 48.77 | 50.25 | 47.22 | 53.07 |
|
|
| Moderate/poor/very poor | 26.23 | 21.44 | 19.66 | 23.23 |
|
| Chronic diseases (%)d | 43.86 | 40.65 | 41.30 | 39.86 | |
|
|
| |||||
|
|
| Almost no risk | 42.00 | 41.37 | 44.92 | 37.86 |
|
|
| Slight risk | 39.41 | 40.91 | 39.18 | 42.69 |
|
|
| Moderate risk | 11.52 | 11.88 | 12.72 | 11.00 |
|
|
| High risk | 2.27 | 2.52 | 1.26 | 3.76 |
|
| ||||||
|
| Health advice obtained by physician | 46.75 | 48.30 | 52.20 | 44.46 | |
|
| Diabetes risk communicated by physician | 6.09 | 5.89 | 5.12 | 6.56 | |
aSample sizes (n) are given as unweighted.
bPercentages (%) are given as weighted.
cAt least one parent or sibling was diagnosed with diabetes.
dAny chronic disease besides diabetes.
Sample characteristics of the initial sample and of the sample of smartphone owners, app users, and nonapp users among individuals with known type 2 diabetes. (Data are given as weighted percentage or mean [SD]. Missing data were less than 5% for all variables).
| Variables | Initial sample (n=1149) | Smartphone ownersa (481/1149; 42.26%b) | App usersa (171/481; 41.10%) | Nonapp usersa (310/481; 58.90%) | |||||||
|
| |||||||||||
|
|
| 67.37 (12.06) | 61.64 (11.73) | 58.80 (13.95) | 63.61 (9.43) | ||||||
|
|
| ||||||||||
|
|
| ≥65 | 62.35 | 41.89 | 31.07 | 49.55 | |||||
|
|
| 18-64 | 37.65 | 58.11 | 68.93 | 50.45 | |||||
|
| Gender, female (%) | 50.95 | 43.58 | 51.01 | 38.40 | ||||||
|
|
| ||||||||||
|
|
| Low | 49.15 | 37.19 | 33.94 | 39.45 | |||||
|
|
| Middle | 38.35 | 46.28 | 52.22 | 42.13 | |||||
|
|
| High | 12.43 | 16.54 | 13.84 | 18.42 | |||||
|
| |||||||||||
|
| Diabetes duration (years), mean (SD) | 13.78 (9.75) | 11.79 (8.61) | 11.12 (8.41) | 12.25 (8.74) | ||||||
|
| BMI (kg/m²), mean (SD) | 30.53 (5.78) | 30.81 (6.11) | 30.59 (6.39) | 30.97 (5.92) | ||||||
|
|
| ||||||||||
|
|
| BMI<25 | 15.25 | 15.51 | 19.12 | 12.99 | |||||
|
|
| 25≤BMI<30 | 35.61 | 33.25 | 30.18 | 35.40 | |||||
|
|
| BMI≥30 | 46.78 | 50.15 | 49.70 | 50.47 | |||||
|
| Diabetes-related complicationsc, at least one (%) | 34.33 | 32.23 | 30.77 | 33.26 | ||||||
|
| Comorbiditiesd, at least one (%) | 31.01 | 24.42 | 20.96 | 26.84 | ||||||
|
| Treatment with insulin (%) | 45.54 | 41.05 | 46.08 | 37.54 | ||||||
|
| Treatment with tablets (%) | 69.81 | 75.02 | 76.38 | 74.08 | ||||||
|
| Treatment with healthy diet or physical activity (%) | 73.18 | 78.94 | 83.29 | 75.91 | ||||||
|
|
| ||||||||||
|
|
| Glucose meter with blood sampling | 62.12 | 61.35 | 61.78 | 61.05 | |||||
|
|
| Subcutaneous fatty tissue in addition to or instead of a glucose meter | 4.96 | 5.10 | 8.34 | 2.84 | |||||
|
|
| No use of measurements or no blood sugar measuring in the last 7 days | 31.75 | 32.99 | 28.94 | 35.82 | |||||
|
| |||||||||||
|
|
|
|
|
|
| ||||||
|
|
| Very good | 6.51 | 8.82 | 8.92 | 8.74 | |||||
|
|
| Good | 40.78 | 43.35 | 43.52 | 43.23 | |||||
|
|
| Moderate/poor/very poor | 52.58 | 47.78 | 47.56 | 47.93 | |||||
|
| Personal control over diabetes, mean (SD)f | 16.02 (2.79) | 16.86 (2.67) | 16.87 (2.95) | 16.85 (2.47) | ||||||
|
| |||||||||||
|
| Health advice obtained by physician (%) | 81.91 | 83.60 | 86.53 | 81.56 | ||||||
aSample sizes (n) are given as unweighted.
bPercentages (%) are given as weighted.
cIncluding kidney disease, eye disease, nervous disease, diabetic foot lesions, and amputations.
dIncluding heart attack, stroke, and coronary heart disease.
eMultiple answers were eligible.
fPossible score range: 4-20.
Figure 2App use for single and multiple target behaviors among people without known diabetes and people with known type 2 diabetes. Frequencies are given as weighted percentage and n. App use targeting blood sugar adjustment was assessed only in people with type 2 diabetes and thus is not presented for people without known diabetes in the single and multiple condition.
Associations with app use among people without known diabetes owning a smartphone (n=1690). Analyses were based on imputed and weighted data. Model 1: adjusted for age and gender. Model 2: fully adjusted for all determinants. Model statistics for model 2 (values were averaged based on 20 imputed datasets): Hosmer and Lemeshow test: χ²8=13.8; P=.16; area under the receiver operating characteristic curve=0.68.
| Factors | Model 1 | Model 2 | |||||||||
|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||||||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| ≥65 | —b | — | — | — | |||||
|
|
| 45-64 | 1.74 (1.21-2.50) | .003 | 1.76 (1.19-2.59) | .004 | |||||
|
|
| 18-44 | 3.07 (2.16-4.36) | <.001 | 3.89 (2.62-5.78) | <.001 | |||||
|
| Gender (reference: male)a | 0.96 (0.79-1.16) | .63 | 1.04 (0.85-1.29) | .69 | ||||||
|
|
| ||||||||||
|
|
| Low | — | — | — | — | |||||
|
|
| Middle | 1.07 (0.83-1.38) | .61 | 1.23 (0.94-1.61) | .13 | |||||
|
|
| High | 0.74 (0.56-0.97) | .03 | 0.86 (0.64-1.15) | .30 | |||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| BMI<25 | — | — | — | — | |||||
|
|
| 25≤BMI<30 | 1.56 (1.24-1.96) | <.001 | 1.58 (1.24-2.02) | <.001 | |||||
|
|
| BMI≥30 | 1.84 (1.35-2.51) | <.001 | 2.07 (1.45-2.96) | <.001 | |||||
|
| Hypertension diagnosis (reference: no) | 1.45 (1.14-1.85) | .003 | 1.31 (1.01-1.70) | .045 | ||||||
|
| Physical activity (≥5 hours per week; reference: <5 hours) | 1.10 (0.87-0.137) | .43 | 1.00 (0.79-1.28) | .97 | ||||||
|
|
| ||||||||||
|
|
| Not smoking | — | — | — | — | |||||
|
|
| Formerly smoking | 1.66 (1.30-2.12) | <.001 | 1.51 (1.17-1.96) | .002 | |||||
|
|
| Currently smoking | 1.54 (1.22-1.94) | <.001 | 1.58 (1.24-2.01) | <.001 | |||||
|
| Family history of diabetes (reference: no) | 1.17 (0.93-1.49) | .19 | 1.29 (1.00-1.66) | .06 | ||||||
|
| |||||||||||
|
|
| ||||||||||
|
|
| Moderate/poor/very poor | — | — | — | — | — | ||||
|
|
| Good | 0.91 | 0.70-1.18 | .47 | 1.22 (0.90-1.64) | .20 | ||||
|
|
| Very good | 1.28 | 0.96-1.71 | .10 | 2.21 (1.55-3.16) | <.001 | ||||
|
| Chronic diseases (reference: no) | 1.27 | 1.04-1.56 | .02 | 1.48 (1.16-1.88) | .002 | |||||
|
|
| ||||||||||
|
|
| Almost no risk | — | — | — | — | — | ||||
|
|
| Slight risk | 0.85 | 0.68-1.06 | .14 | 0.78 (0.62-0.99) | .04 | ||||
|
|
| Moderate risk | 1.07 | 0.78-1.50 | .67 | 0.92 (0.64-1.33) | .67 | ||||
|
|
| High risk | 0.29 | 0.14-0.60 | .001 | 0.23 (0.10-0.51) | <.001 | ||||
|
| |||||||||||
|
| Health advice obtained by physician (reference: no) | 1.49 | 1.23-1.81 | <.001 | 1.48 (1.20-1.83) | <.001 | |||||
|
| Diabetes risk communicated by physician (reference: no) | 0.82 | 0.54-1.23 | .34 | 0.69 (0.43-1.11) | .13 | |||||
aThe separate model was not adjusted for any other variable.
bReference group.
Associations with app use among people with type 2 diabetes owning a smartphone (n=481). Analyses were based on imputed and weighted data. Model 1: adjusted for age and gender. Model 2: fully adjusted for all determinants. Model statistics for model 2 (values were averaged based on 20 imputed datasets). Hosmer and Lemeshow test: χ²8=9.4; P=.33; area under the receiver operating characteristic curve=0.69.
| Factors | Model 1 | Model 2 | ||||||||
|
| Odds ratio (95% CI) | Odds ratio (95% CI) | ||||||||
|
| ||||||||||
|
|
| |||||||||
|
|
| ≥a | —c | — | — | — | ||||
|
|
| 18-64 | 2.16 (1.47-3.19) | <.001 | 1.84 (1.19-2.86) | .007 | ||||
|
| Gender (reference: male)b | 1.68 (1.15-2.44) | .007 | 1.61 (1.07-2.43) | .02 | |||||
|
|
| |||||||||
|
|
| Low | — | — | — | — | ||||
|
|
| Middle | 1.36 (0.89-2.06) | .16 | 1.47 (0.95-2.21) | .09 | ||||
|
|
| High | 0.97 (0.72-1.30) | .98 | 1.10 (0.63-2.01) | .75 | ||||
|
| ||||||||||
|
| Diabetes duration (years) | 1.00 (0.97-1.02) | .72 | 0.99 (0.96-1.01) | .26 | |||||
|
|
| |||||||||
|
|
| BMI<25 | — | — | — | — | ||||
|
|
| 25≤BMI<30 | 0.62 (0.34-1.11) | .11 | 0.63 (0.34-1.17) | .14 | ||||
|
|
| BMI≥30 | 0.60 (0.34-1.05) | .07 | 0.62 (0.34-1.12) | .11 | ||||
|
|
| |||||||||
|
|
| At least one complication (reference: no complication) | 0.98 (0.65-1.48) | .92 | 0.97 (0.61-1.54) | .89 | ||||
|
| ||||||||||
|
|
| |||||||||
|
|
| At least one comorbidity (reference: no comorbidity) | 0.89 (0.56-1.42) | .63 | 0.87 (0.53-1.43) | .59 | ||||
|
| Treatment with insulin (reference: no) | 1.45 (0.98-2.14) | .06 | 1.53 (0.92-2.55) | .11 | |||||
|
| Treatment with tablets (reference: no) | 1.05 (0.68-1.63) | .82 | 1.10 (0.67-1.79) | .71 | |||||
|
| Treatment with healthy diet or physical activity | 1.56 (1.24-1.96) | .07 | 1.58 (0.94-2.68) | .09 | |||||
|
|
| |||||||||
|
|
| Glucose meter with blood sampling | — | — | — | — | ||||
|
|
| Blood glucose sensor in subcutaneous fatty tissue in addition to or instead of a glucose meter | 2.50 (1.00-6.24) | .05 | 2.74 (1.06-7.09) | .04 | ||||
|
|
| No use of measurements or no blood sugar measuring in the last 7 days | 0.76 (0.50-1.16) | .20 | 0.85 (0.52-1.38) | .50 | ||||
|
| ||||||||||
|
|
| |||||||||
|
|
| Moderate/poor/very poor | — | — | — | — | ||||
|
|
| Good | 1.06 (0.71-1.58) | .78 | 1.01 (0.65-1.58) | .97 | ||||
|
|
| Very good | 0.90 (0.45-1.81) | .78 | 1.01 (0.49-2.10) | .98 | ||||
|
| Personal control over diabetes | 0.97 (0.90-1.04) | .40 | 0.98 (0.91-1.06) | .60 | |||||
|
| ||||||||||
|
| Health advice obtained by physician (reference: no) | 1.39 (0.81-2.39) | .23 | 1.28 (0.72-2.28) | .40 | |||||
aThe separate model was not adjusted for any other variable.
bAge categories 18-44 and 45-64 years were merged because of insufficient case numbers in the age category 18-44 years across other variables.
cReference group.
dComplications asked in this survey were kidney disease, eye disease, nervous disease, diabetic foot lesions, and amputations.
eComorbidities asked in this survey were heart attack, stroke, and coronary heart disease.